Over 1150 Total Lots Up For Auction at Three Locations - WI 07/09, NJ Cleansweep 07/10, CA 07/11

Q&A with Dr. Bennett Greenspan, SNMMI President 2017-2018

by Sean Ruck, Contributing Editor | June 09, 2017
Molecular Imaging
From the June 2017 issue of HealthCare Business News magazine


HCB News: What are you most excited about at the upcoming annual show and conference?
BG: I’m looking forward to seeing the data on the new agents to see how successful they are. Presenting our value initiative about how nuclear medicine provides value to patients and health care overall will also be exciting.

Our value initiative covers five domains:
stats
DOTmed text ad

You don’t have to invest heavily in CT technology to achieve your Coronary CTA goals

Fast-moving cardiac structures have a big impact on imaging. Fujifilm’s SCENARIA View premium performance CT brings solutions to address motion in Coronary CTA while delivering unique dose saving and workflow increasing benefits.

stats
• Quality of practice, which provides focus on improvement in quality of studies and interpretations, and use of diagnostics and therapeutics, to promote better patient outcomes.

• Research and development, to develop new radiopharmaceuticals in a wide range of diagnostic procedures, and new radiopharmaceuticals for radionuclide therapy.

• The workforce pipeline, to attract high quality candidates to nuclear medicine. Also to get radiology residents more interested in nuclear medicine.

• Advocacy, explaining to legislators, regulators and payors the value of nuclear medicine and molecular imaging.

• And outreach to referring clinicians, patients and the public.

The value initiative will help direct our development of the new strategic plan of the SNMMI for the next three to five years.

Back to HCB News

You Must Be Logged In To Post A Comment